CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway

Lignende værker

• Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma
  af: Zhongkai Zhang, et al.
  Udgivet: (2020-11-01)
• In Skeletal Muscle Fibers, Protein Kinase Subunit CSNK2A1/CK2α Is Required for Proper Muscle Homeostasis and Structure and Function of Neuromuscular Junctions
  af: Mira Merholz, et al.
  Udgivet: (2022-12-01)
• The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
  af: Hye Jeong Park, et al.
  Udgivet: (2018-05-01)
• IL-13Rα2 Is Involved in Resistance to Doxorubicin and Survival of Osteosarcoma Patients
  af: Maryam Karamikheirabad, et al.
  Udgivet: (2024-11-01)
• Loss of Protein Kinase Csnk2b/CK2β at Neuromuscular Junctions Affects Morphology and Dynamics of Aggregated Nicotinic Acetylcholine Receptors, Neuromuscular Transmission, and Synaptic Gene Expression
  af: Nane Eiber, et al.
  Udgivet: (2019-08-01)